ClinicalTrials.gg
Sign In

Duodenal Neoplasms clinical trials

The registry lists 51 studies for Duodenal Neoplasms across more than 10 countries. 14 are recruiting or about to start. 11 of them are mainly about Duodenal Neoplasms (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-01.

Get an email when these change. Save the Duodenal Neoplasms studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
16
Status unknown
13
Recruiting
11
Withdrawn
3
Terminated
3
Not yet recruiting
2

Phase

Phase 2
8
Phase 1
3
Phase 4
3
Phase 3
2

Where

United States
13
China
6
Italy
3
Netherlands
3
Egypt
3
Sweden
3

Who runs them

Wakayama Medical University (3) · Weill Medical College of Cornell University (2) · National Cancer Institute (NCI) (2) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1) · Fudan University (1) · Institut Mutualiste Montsouris (1) · Odense University Hospital (1) · Minia University (1)

What is being tested here

Drugs under test in Duodenal Neoplasms studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Hydrocortisone202
Liposomal Bupivacaine101
Bupivacaine101
Tranexamic Acid101
Octreotide001
Irinotecan001
Ursodeoxycholic Acid011
Obeticholic acid001
Pantoprazole001
Rivaroxaban001

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 11 Duodenal Neoplasms studies recruiting now, 6 (55%) set no upper age limit and 1 (9%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (9%) take healthy volunteers.

Recruiting studies that take each age, of 11
AgeWomenMen
100 (0%)0 (0%)
1810 (91%)10 (91%)
3011 (100%)11 (100%)
4011 (100%)11 (100%)
5011 (100%)11 (100%)
6511 (100%)11 (100%)
7511 (100%)11 (100%)
859 (82%)9 (82%)

Across all 51 studies, recruiting or not: 12% stop at 75 or younger and 0% at 65; 10% take children; 0% are for women only and 0% for men only; 4% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 51. Browse all 51 → or search them.